| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |